About Novo Nordisk
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 75 countries and markets its products in more than 180 countries.
Novo Nordisk in China
As the leader in the Chinese diabetes market, Novo Nordisk has always been committed to changing diabetes. Since its establishment in 1994, the Novo Nordisk (China) Pharmaceuticals Co., Ltd. has been prominently growing its presence in the country. Headquartered in Beijing, Novo Nordisk China has established a distribution network throughout the country, providing services to patients across mainland China as well as Hong Kong, Macau and Taiwan. As of end-2015, Novo Nordisk had 4,389 employees in China. Novo Nordisk was the first biopharmaceutical company to establish a Research center in China. Located in Beijing, the research center is an integral part of Novo Nordisk’s global R&D system, mandated to develop new products and production technologies in collaboration with the company headquarters. Novo Nordisk Tianjin Plant is a strategic overseas production base of Novo Nordisk. Thanks to massive capital investment and a technological expertise, Novo Nordisk Tianjin Plant is now capable of supplying diabetes treatment products to both the Chinese and the global markets. The unrelenting development of Novo Nordisk in China directly reflects the Company’s long-term commitment to the Chinese market.
IGP Position
Want to help to bring life-changing products all over the world? The International Chinese Graduate Program is tailored newly-graduated Chinese master's students and is an ideal opportunity to join a successful and ambitious international company. The program is based in our office in Beijing and is offering positions in six different departments: Diabetes Marketing, Finance, Market Access & Public Affairs, Commercial, Clinical & Medical & Regulatory and HR & Communication. This is a great opportunity for future business leaders to gain international experience in a world-leading company. Read the blog to find out how our current graduates are getting on.
What you will be doing
The International Chinese Graduate Program for newly graduated master's students is an 18-month journey, consisting of three rotations. The rotations are all characterised by a steep learning curve and high expectations will be set for you. The flow and content of the rotations are shaped individually to suit your skills and development needs while meeting our business requirements and addressing our focus areas. All rotations are shaped as shown below:
Rotation 1
The first rotation takes place in our regional headquarters in Beijing, China.
Rotation 2
The second rotation brings you to our corporate headquarters in Copenhagen, Denmark.
Rotation 3
Finally, your third rotation is back in the regional headquarters in China.
The graduate profiles - General Requirements
• Recent Master degree
Finance, Marketing, Business, biopharmaceutical, pharmacy related background.
• Outstanding academic achievements
• Fluent in spoken and written English
• International mindset/culturally adaptable
• Mobility
• Personal competencies:
○ Drive
○ Results oriented
○ Ready for change
○ Team player
○ Proactive
○ Good communicator
